AstraZeneca PLC
LSE:AZN

Watchlist Manager
AstraZeneca PLC Logo
AstraZeneca PLC
LSE:AZN
Watchlist
Price: 11 808 GBX 0.2% Market Closed
Market Cap: 183.1B GBX
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+7%
Revenue
Forecast
+11%
Operating Income
Forecast
+16%
Net Income
Forecast
N/A

Wall Street
Price Targets

AZN Price Targets Summary
AstraZeneca PLC

Wall Street analysts forecast AZN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AZN is 14 190.79 GBX with a low forecast of 6 864.74 GBX and a high forecast of 19 950 GBX.

AZN Lowest Forecast
Wall Street Target
6 864.74 GBX
42% Downside
AZN Average Forecast
Wall Street Target
14 190.79 GBX
20% Upside
AZN Highest Forecast
Wall Street Target
19 950 GBX
69% Upside
Lowest
Price Target
6 864.74 GBX
42% Downside
Average
Price Target
14 190.79 GBX
20% Upside
Highest
Price Target
19 950 GBX
69% Upside
AstraZeneca PLC Competitors:
Price Targets
4519
Chugai Pharmaceutical Co Ltd
22% Upside
688321
Shenzhen Chipscreen Biosciences Co Ltd
105% Upside
002422
Sichuan Kelun Pharmaceutical Co Ltd
39% Upside
M
MANKIND
Mankind Pharma Ltd
27% Upside
4519
Chugai Pharmaceutical Co Ltd
22% Upside
688321
Shenzhen Chipscreen Biosciences Co Ltd
105% Upside
002422
Sichuan Kelun Pharmaceutical Co Ltd
39% Upside
M
MANKIND
Mankind Pharma Ltd
27% Upside
600329
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
48% Upside
AXSM
Axsome Therapeutics Inc
43% Upside

Revenue
Forecast

Revenue Estimate
AstraZeneca PLC

For the last 8 years the compound annual growth rate for AstraZeneca PLC's revenue is 11%. The projected CAGR for the next 3 years is 7%.

11%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
AstraZeneca PLC

For the last 8 years the compound annual growth rate for AstraZeneca PLC's operating income is 15%. The projected CAGR for the next 3 years is 19%.

15%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-38%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
AstraZeneca PLC

For the last 8 years the compound annual growth rate for AstraZeneca PLC's net income is 9%. The projected CAGR for the next 3 years is 36%.

9%
Past Growth
36%
Estimated Growth
Estimates Accuracy
-51%
Average Miss
What are analyst estimates?

See Also

Summary
AZN intrinsic value, competitors valuation, and company profile.
DCF Valuation
AZN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AZN stock valuation using valuation multiples.
Wall Street Estimates
AZN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AZN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AZN's stock price target?
Price Target
14 190.79 GBX

According to Wall Street analysts, the average 1-year price target for AZN is 14 190.79 GBX with a low forecast of 6 864.74 GBX and a high forecast of 19 950 GBX.

What is AstraZeneca PLC's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for AstraZeneca PLC's revenue is 11%. The projected CAGR for the next 3 years is 7%.

What is AstraZeneca PLC's Operating Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for AstraZeneca PLC's operating income is 15%. The projected CAGR for the next 3 years is 19%.

What is AstraZeneca PLC's Net Income forecast?
Projected CAGR
36%

For the last 8 years the compound annual growth rate for AstraZeneca PLC's net income is 9%. The projected CAGR for the next 3 years is 36%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 240,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.